ASRS 2023: Aaron Lee, MD, on the future of deep learning models in ophthalmology

News
Video

At the 2023 ASRS meeting in Seattle, Washington, Aaron Lee, MD, shared how new techniques are expanding the options for deep learning in ophthalmology.

Aaron Lee, MD, shared how research and new techniques are expanding the options for deep learning in ophthalmology. At the 2023 ASRS meeting in Seattle, Washington, he spoke more about his research and how changes are making new training possible.

Video Transcript

Editor's note - This transcript has been edited for clarity.

Aaron Lee, MD:

Okay, I'm Aaron Lee. I'm at the University of Washington. I'm an associate professor there. My research for the last couple of years has really been on the focus of artificial intelligence and big data, and trying to understand and uncover new associations in opthalmic diseases using these very powerful techniques. But one of the critical ingredients that has been really missing in our field has been the availability of large datasets, large imaging datasets, in particular, that you need to train these very large, deep learning models.


And so the presentation I'm giving is really about how to build the next future of large datasets that everybody can use to train deep learning models, in the field of ophthalmology. One of the things that's really important for this is the standardisation of those images so that it's easy for researchers to use.
Traditionally, those images have always been sort of locked up in a way that it makes it very difficult for people to open, but actually Heidelberg, with the Heyex PACS system, allowed for those images to be unlocked in a way where you can just literally copy them off the hard drive and open them in a third party viewer.

And because Heidelberg made this move, the whole industry now is moving in this direction. And it's really sort of transforming the landscape of the availability of this kind of data. So we're very, sort of excited, about the new future of data science in retina research in particular. And so that's really sort of the focus of my research and what we're doing for the next couple of years.

Recent Videos
Thomas Aaberg, MD, gives an update on Neurotech Pharmaceuticals NT-501 device for the potential treatment of retinitis pigmentosa and age-related macular degeneration, including a projected PDUFA date from the FDA at the annual ASRS meeting in Stockholm, Sweden.
Sruthi Arepalli, MD, spoke with Modern Retina about her presentation, "Assessing retinal vascular changes in alzheimer disease with radiomics: A preliminary study of fundus photography" at the annual ASRS meeting in Stockholm, Sweden.
Nathan Steinle, MD, spoke with Modern Retina about the ongoing research on the durability of sozinibercept in combination therapy with anti-VEGF-A treatments at the annual ASRS meeting in Stockholm, Sweden.
Deepak Sambhara, MD, shared an overview of his paper-on-demand, which covered real-world safety and efficacy of aflibercept, 8 mg in the treatment of neovascular age-related macular degeneration at the annual ASRS meeting in Stockholm, Sweden.
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
© 2024 MJH Life Sciences

All rights reserved.